Free Trial

What is Zacks Research's Forecast for MTD FY2024 Earnings?

Mettler-Toledo International logo with Computer and Technology background

Mettler-Toledo International Inc. (NYSE:MTD - Free Report) - Stock analysts at Zacks Research increased their FY2024 EPS estimates for Mettler-Toledo International in a note issued to investors on Thursday, November 28th. Zacks Research analyst R. Department now forecasts that the medical instruments supplier will post earnings per share of $40.40 for the year, up from their previous estimate of $40.28. The consensus estimate for Mettler-Toledo International's current full-year earnings is $40.42 per share. Zacks Research also issued estimates for Mettler-Toledo International's Q2 2025 earnings at $10.34 EPS, FY2025 earnings at $42.39 EPS, Q3 2026 earnings at $11.88 EPS and FY2026 earnings at $48.78 EPS.

Several other equities research analysts have also recently issued reports on the company. Wells Fargo & Company lowered their price objective on Mettler-Toledo International from $1,400.00 to $1,350.00 and set an "equal weight" rating on the stock in a report on Monday, November 11th. JPMorgan Chase & Co. lifted their price target on Mettler-Toledo International from $1,300.00 to $1,400.00 and gave the stock a "neutral" rating in a research note on Monday, August 5th. Stifel Nicolaus reduced their price objective on Mettler-Toledo International from $1,550.00 to $1,450.00 and set a "buy" rating for the company in a research note on Monday, November 11th. Evercore ISI raised their price objective on Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the company an "in-line" rating in a report on Tuesday, October 1st. Finally, Robert W. Baird dropped their target price on shares of Mettler-Toledo International from $1,375.00 to $1,310.00 and set a "neutral" rating for the company in a report on Monday, November 11th. Two investment analysts have rated the stock with a sell rating, five have assigned a hold rating and two have given a buy rating to the company's stock. Based on data from MarketBeat, Mettler-Toledo International currently has a consensus rating of "Hold" and an average target price of $1,338.75.

View Our Latest Research Report on Mettler-Toledo International

Mettler-Toledo International Stock Performance

Shares of MTD stock traded up $9.64 on Monday, reaching $1,260.84. 99,472 shares of the company were exchanged, compared to its average volume of 136,732. Mettler-Toledo International has a 1 year low of $1,068.33 and a 1 year high of $1,546.93. The business has a 50-day moving average price of $1,342.27 and a 200 day moving average price of $1,390.47. The company has a market cap of $26.61 billion, a price-to-earnings ratio of 33.99, a P/E/G ratio of 4.13 and a beta of 1.16.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last released its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $10.00 by $0.21. The firm had revenue of $954.54 million for the quarter, compared to analysts' expectations of $941.93 million. Mettler-Toledo International had a net margin of 21.15% and a negative return on equity of 531.78%.

Insider Buying and Selling at Mettler-Toledo International

In other Mettler-Toledo International news, Director Elisha W. Finney sold 76 shares of the stock in a transaction that occurred on Monday, November 11th. The shares were sold at an average price of $1,311.75, for a total value of $99,693.00. Following the sale, the director now directly owns 240 shares of the company's stock, valued at approximately $314,820. This represents a 24.05 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link. 1.94% of the stock is currently owned by company insiders.

Institutional Trading of Mettler-Toledo International

Several institutional investors have recently modified their holdings of MTD. PineStone Asset Management Inc. boosted its position in shares of Mettler-Toledo International by 127.4% in the 2nd quarter. PineStone Asset Management Inc. now owns 259,629 shares of the medical instruments supplier's stock valued at $362,855,000 after purchasing an additional 145,453 shares during the period. International Assets Investment Management LLC boosted its holdings in shares of Mettler-Toledo International by 149,870.0% in the third quarter. International Assets Investment Management LLC now owns 89,982 shares of the medical instruments supplier's stock valued at $134,946,000 after acquiring an additional 89,922 shares during the period. Massachusetts Financial Services Co. MA grew its position in shares of Mettler-Toledo International by 32.5% during the second quarter. Massachusetts Financial Services Co. MA now owns 142,944 shares of the medical instruments supplier's stock worth $199,777,000 after acquiring an additional 35,048 shares during the last quarter. Wellington Management Group LLP increased its holdings in shares of Mettler-Toledo International by 17.5% in the 3rd quarter. Wellington Management Group LLP now owns 177,963 shares of the medical instruments supplier's stock valued at $266,891,000 after acquiring an additional 26,443 shares during the period. Finally, Barclays PLC raised its position in Mettler-Toledo International by 8.3% in the 3rd quarter. Barclays PLC now owns 256,602 shares of the medical instruments supplier's stock valued at $384,822,000 after purchasing an additional 19,609 shares during the last quarter. Hedge funds and other institutional investors own 95.07% of the company's stock.

About Mettler-Toledo International

(Get Free Report)

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.

Recommended Stories

Earnings History and Estimates for Mettler-Toledo International (NYSE:MTD)

Should you invest $1,000 in Mettler-Toledo International right now?

Before you consider Mettler-Toledo International, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Mettler-Toledo International wasn't on the list.

While Mettler-Toledo International currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Broadcom Hits $1 Trillion – Can This AI Powerhouse Go Higher?
SoundHound Stock Explodes Again – Is a Major Breakout Coming?
How Fintech Strategy at FinWise Bancorp and CEO Vision Are Driving 78% Gains

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines